During our 100+ years as a full-service, growth investment bank, we‘ve empowered our clients’ success by delivering a depth and breadth of insights across a broad range of sectors and capabilities.
Ahead of the Curve®
Jan 17, 2024
Drug Pricing Survey Again Suggests Positive Outlook
Read More >
Ahead of the Curve®
Dec 14, 2023
AI In Drug Development: From Hype To The Clinic & Beyond
Read More >
Ahead of the Curve®
Nov 29, 2023
Alzheimer’s Coming of Age Moment
Read More >
Ahead of the Curve®
Nov 28, 2023
Will GLP-1s Eat The World?
Read More >
Ahead of the Curve®
Sep 19, 2023
Investors Guide to Immuno-Oncology
Read More >
Ahead of the Curve®
Jun 9, 2023
5th Annual Investor Primer on Antibody Drug Conjugates
Read More >
May 5, 2023
Best ESG Investment Ideas for 2023
Read More >
Ahead of the Curve®
Apr 25, 2023
A Primer On The Next Generation Of Radiopharmaceuticals
Read More >
Podcast
Feb 9, 2023
Drug Pricing Outlook
Read More >
Ahead of the Curve®
Jan 27, 2023
Drug Pricing Survey Again Suggests Positive Outlook
Read More >
Ahead of the Curve®
Jan 27, 2023
The Price Is (Not) Right: Discounts, 340B, Access, And IRA
Read More >
Ahead of the Curve®
Dec 19, 2022
Modernizing R&D: A Primer On Decentralized Clinical Trials
Read More >
In order to optimize our website for you and to be able to continuously improve it, we use cookies. By continuing to use the website, you agree to the use of cookies. Further information on cookies can be found in our Privacy Policy.
